AVBP R&D Expenses
Arrivent Biopharma Inc · R&D Expenses
AVBP R&D Expenses
Latest reported$144.30Mperiod ending
AVBP TTM R&D Expenses ($30.43M → $144.30M)
TTM R&D Expenses
High-resolution chart · PNG
AVBP r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 144,298,000 | |
| 129,679,000 | |
| 153,351,000 | |
| 141,339,000 | |
| 129,260,000 | |
| 123,318,000 | |
| 79,004,000 | |
| 78,851,000 | |
| 73,043,000 | |
| 71,623,000 | |
| 64,884,000 | |
| 53,521,000 | |
| 49,330,000 | |
| 34,820,500 | |
| 30,433,000 |